Excessive Penile Norepinephrine Level Underlies Impaired Erectile Function in Adenosine A1 Receptor Deficient Mice

Journal of Sexual Medicine

Volumn 9, Issue 10, 2012, Pages 2552-2561

  Ning, Chen ^a,b,c   Qi, Lin ^a   Wen, Jiaming ^b,c,d   Zhang, Yujin ^b,c   Zhang, Weiru ^a,b,c   Wang, Wei ^a,b,c   Blackburn, Michael ^b,c   Kellems, Rodney ^b,c   Xia, Yang ^b,c  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Adenosine; Cavernosal Smooth Muscle; Erectile Function; Norepinephrine; Penile Tissue

Indexed keywords

ADENOSINE A1 RECEPTOR; MYOSIN LIGHT CHAIN; NORADRENALIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS CAVERNOSUM; ENZYME LINKED IMMUNOSORBENT ASSAY; ERECTILE DYSFUNCTION; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; INTRACAVERNOSAL PRESSURE; MALE GENITAL TRACT PARAMETERS; MOUSE; NERVE CELL; NERVE STIMULATION; NONHUMAN; NORADRENALIN BLOOD LEVEL; OUTCOME ASSESSMENT; PENIS; PENIS ERECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SMOOTH MUSCLE CONTRACTION; SYSTEMIC CIRCULATION;

EID: 84867400490     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2012.02896.x     Document Type: Article

References (37)

1. Simonsen U, Garcia-Sacristan A, Prieto D. Penile arteries and erection. J Vasc Res 2002;39:283-303.
2. Dean RC, Lue TF. Physiology of penile erection and pathophysiology of erectile dysfunction. Urol Clin North Am 2005;32:379-95.
3. Lin CS, Lin G, Lue TF. Cyclic nucleotide signaling in cavernous smooth muscle. J Sex Med 2005;2:478-91.
4. Yonezawa A, Sakurada S, Furukawa K, Kimura Y. [Adenosine and adenosine triphosphate]. Nihon Rinsho 2002;60(suppl 6):52-6.
5. Filippi S, Mancini M, Amerini S, Bartolini M, Natali A, Mancina R, Forti G, Ledda F, Maggi M. Functional adenosine receptors in human corpora cavernosa. Int J Androl 2000;23:210-7.
6. Mi T, Abbasi S, Zhang H, Uray K, Chunn JL, Xia LW, Molina JG, Weisbrodt NW, Kellems RE, Blackburn MR, Xia Y. Excess adenosine in murine penile erectile tissues contributes to priapism via A2B adenosine receptor signaling. J Clin Invest 2008;118:1491-501.
7. Phatarpekar PV, Wen J, Xia Y. Role of adenosine signaling in penile erection and erectile disorders. J Sex Med 2010;7:3553-64.
8. Wen J, Jiang X, Dai Y, Zhang Y, Tang Y, Sun H, Mi T, Kellems RE, Blackburn MR, Xia Y. Adenosine deaminase enzyme therapy prevents and reverses the heightened cavernosal relaxation in priapism. J Sex Med 2010;7:3011-22.
9. Fredholm BB, IJzerman AP, Jacobson KA, Linden J, Muller CE. International union of basic and clinical pharmacology. LXXXI. Nomenclature and classification of adenosine receptors-An update. Pharmacol Rev 2011;63:1-34.
10. Wen J, Dai Y, Zhang Y, Zhang W, Kellems RE, Xia Y. Impaired erectile function in CD73-deficient mice with reduced endogenous penile adenosine production. J Sex Med 2011;8:2172-80.
11. Wen J, Grenz A, Zhang Y, Dai Y, Kellems RE, Blackburn MR, Eltzschig HK, Xia Y. A2B adenosine receptor contributes to penile erection via PI3K/AKT signaling cascade-mediated eNOS activation. FASEB J 2011;25:2823-30.
12. Wen J, Xia Y. Adenosine signaling: Good or bad in erectile function? Arterioscler Thromb Vasc Biol 2012;32:845-50.
13. Sun D, Samuelson LC, Yang T, Huang Y, Paliege A, Saunders T, Briggs J, Schnermann J. Mediation of tubuloglomerular feedback by adenosine: Evidence from mice lacking adenosine 1 receptors. Proc Natl Acad Sci U S A 2001;98:9983-8.
14. Chen JF, Huang Z, Ma J, Zhu J, Moratalla R, Standaert D, Moskowitz MA, Fink JS, Schwarzschild MA. A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice. J Neurosci 1999;19:9192-200.
15. Bivalacqua TJ, Musicki B, Hsu LL, Gladwin MT, Burnett AL, Champion HC. Establishment of a transgenic sickle-cell mouse model to study the pathophysiology of priapism. J Sex Med 2009;6:2494-504.
16. Champion HC, Bivalacqua TJ, Takimoto E, Kass DA, Burnett AL. Phosphodiesterase-5A dysregulation in penile erectile tissue is a mechanism of priapism. Proc Natl Acad Sci U S A 2005;102:1661-6.
17. Andersson KE, Wagner G. Physiology of penile erection. Physiol Rev 1995;75:191-236.
18. Mizusawa H, Hedlund P, Hakansson A, Alm P, Andersson KE. Morphological and functional in vitro and in vivo characterization of the mouse corpus cavernosum. Br J Pharmacol 2001;132:1333-41.
19. Hedlund P, Alm P, Andersson KE. NO synthase in cholinergic nerves and NO-induced relaxation in the rat isolated corpus cavernosum. Br J Pharmacol 1999;127:349-60.
20. Hedlund P, Ny L, Alm P, Andersson KE. Cholinergic nerves in human corpus cavernosum and spongiosum contain nitric oxide synthase and heme oxygenase. J Urol 2000;164:868-75.
21. von Kugelgen I, Spath L, Starke K. Stable adenine nucleotides inhibit [3H]-noradrenaline release in rabbit brain cortex slices by direct action at presynaptic adenosine A1-receptors. Naunyn Schmiedebergs Arch Pharmacol 1992;346:187-96.
22. Allgaier C, Greber R, Hertting G. Studies on the interaction between presynaptic alpha 2-adrenoceptors and adenosine A1 receptors located on noradrenergic nerve terminals. Naunyn Schmiedebergs Arch Pharmacol 1991;344:187-92.
23. von Kugelgen I, Starke K. Kainate receptors are involved in the glutamate-induced indirect, purinergic inhibition of [3H]-noradrenaline release in rabbit brain cortex. Naunyn Schmiedebergs Arch Pharmacol 1995;353:46-54.
24. Wardas J. Neuroprotective role of adenosine in the CNS. Pol J Pharmacol 2002;54:313-26.
25. Burnstock G. Physiology and pathophysiology of purinergic neurotransmission. Physiol Rev 2007;87:659-797.
26. Dhalla AK, Shryock JC, Shreeniwas R, Belardinelli L. Pharmacology and therapeutic applications of A1 adenosine receptor ligands. Curr Top Med Chem 2003;3:369-85.
27. Belardinelli L, Linden J, Berne RM. The cardiac effects of adenosine. Prog Cardiovasc Dis 1989;32:73-97.
28. Gao ZG, Jacobson KA. Emerging adenosine receptor agonists. Expert Opin Emerg Drugs 2007;12:479-92.
29. Linden J. Structure and function of A1 adenosine receptors. FASEB J 1991;5:2668-76.
30. Press NJ, Gessi S, Borea PA, Polosa R. Therapeutic potential of adenosine receptor antagonists and agonists. Expert Opin Ther Pat 2007;17:979-91.
31. Tostes RC, Giachini FR, Carneiro FS, Leite R, Inscho EW, Webb RC. Determination of adenosine effects and adenosine receptors in murine corpus cavernosum. J Pharmacol Exp Ther 2007;322:678-85.
32. Lue TF. Erectile dysfunction. N Engl J Med 2000;342:1802-13.
33. Prieto D. Physiological regulation of penile arteries and veins. Int J Impot Res 2008;20:17-29.
34. Becker AJ, Uckert S, Stief CG, Scheller F, Knapp WH, Hartmann U, Jonas U. Cavernous and systemic plasma levels of norepinephrine and epinephrine during different penile conditions in healthy men and patients with erectile dysfunction. Urology 2002;59:281-6.
35. Burnstock G. Historical review: ATP as a neurotransmitter. Trends Pharmacol Sci 2006;27:166-76.
36. Rongen GA, Lenders JW, Lambrou J, Willemsen JJ, Van Belle H, Thien T, Smits P. Presynaptic inhibition of norepinephrine release from sympathetic nerve endings by endogenous adenosine. Hypertension 1996;27:933-8.
37. Takahashi Y, Ishii N, Lue TF, Tanagho EA. Effects of adenosine on canine penile erection. J Urol 1992;148:1323-5.